IJTLD Open · Published 2026-04-01 · DOI 10.5588/ijtldopen.25.0634
BACKGROUND: TB remains the leading cause of death by a single infectious agent globally. Experiencing TB disease also has profound psychological impacts that persist beyond treatment. Anxiety is increasingly recognised as a significant component of TB disease burden, but it is under-studied and the evidence is fragmented. We aimed to address this fragmentation by synthesising the literature on TB, post-TB sequelae, and anxiety. METHODS: We conducted a scoping review for literature published between January 2000 and May 2025 across PubMed, Scopus, Google Scholar, and ClinicalTrials.gov. Eligible studies examined anxiety in active TB or post-TB populations, including quantitative, qualitative, and mixed-methods data, published in English. RESULTS: From 612 records screened, 90 studies met the inclusion criteria. Although 87 reported on anxiety during a TB disease episode, only 3 studies addressed post-TB anxiety. Common risk factors included stigma, social isolation, financial strain, comorbid illness, and fear of recurrence. Findings suggested that anxiety often persists post-treatment, particularly among those with lasting physical limitations and socio-economic disadvantages. Challenges were observed across both low- and high-income countries. CONCLUSION: Anxiety in TB and post-TB populations is widespread, multifactorial, and frequently unresolved after treatment. Additional data to inform intervention development are urgently needed.
Abstract from DOAJ. Public domain (CC0 1.0).
Read the article at the publisher →